Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

January 13, 2021

Carbapenem and Colistin Resistance in Enterobacter: Determinants and Clones

Trends in Microbiology
Zhiyong ZongAlan McNally
January 10, 2021

The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Ziv DadonPhillip D Levin
January 15, 2021

External validation of INCREMENT-CPE score in a retrospective cohort of carbapenemase-producing Klebsiella pneumoniae bloodstream infections in critically ill patients

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Matthaios Papadimitriou-OlivgerisMarkos Marangos
January 14, 2021
Open Access

Role of the mobilome in the global dissemination of the carbapenem resistance gene blaNDM

BioRxiv : the Preprint Server for Biology
Mislav AcmanF. Balloux
January 12, 2021
Open Access

Synergistic effects of zinc oxide nanoparticles and various antibiotics combination against Pseudomonas aeruginosa clinically isolated bacterial strains

Saudi Journal of Biological Sciences
Alshareef O FadwaAhmed M Albarag
January 10, 2021

Epidemiology of Invasive Escherichia coli Infection and Antibiotic Resistance Status among Patients Treated in U.S. Hospitals: 2009-2016

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Elizabeth BegierStephen P Lockhart
January 14, 2021
Open Access

Applicability and performance of EUCAST's rapid antimicrobial susceptibility testing (RAST) on primarily sterile body fluids in blood culture bottles in laboratory routine with total lab automation

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Jasmin Kaur JasujaIrene Burckhardt
January 12, 2021

AmpC- and Extended-spectrum β-lactamase-producing Enterobacteriaceae detected in fresh produce in central Ohio

Journal of Food Protection
Elizabeth ParkerThomas Wittum
January 12, 2021

Effect of Oral Moxifloxacin vs Intravenous Ertapenem Plus Oral Levofloxacin for Treatment of Uncomplicated Acute Appendicitis: The APPAC II Randomized Clinical Trial

JAMA : the Journal of the American Medical Association
Suvi SippolaPaulina Salminen
January 9, 2021
Open Access

Antibiotic resistance in childhood urinary tract infections: A single-center experience

Türk Pediatri Arşivi
Serhat SamancıMuhammet Köşker
January 10, 2021
Open Access

Genomic Characterization of VIM and MCR Co-Producers: The First Two Clinical Cases, in Italy

Vittoria Mattioni MarchettiRoberta Migliavacca
January 12, 2021

Prognostic Factors of Central Venous Catheter-related Bloodstream Infections

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
Zhao Yun XieZhong Ling Yang

Sign up to follow this feed and discover related papers.

Related Feeds


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2021 Meta ULC. All rights reserved